Suppliers / Blackrock Pharmaceuticals

Blackrock Pharmaceuticals

United Kingdom 3 employees Updated 9 July 2026

Blackrock Pharmaceuticals is a finished-dose manufacturer based in United Kingdom. It appears in 5 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with EMA and EDE (AE). Its GMP standing is certified by MHRA (UK).

0
active US DMFs
0
valid CEPs
3
registered plants
5
filings across 2 regulators

Registered plants

Site FDA FEI
MARLOW, United Arab Emirates Not on file
HIGH WYCOMBE, United Kingdom Not on file
MARLOW, United Kingdom Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
EMA 4 None
EDE (AE) 1 None
MHRA (UK) None 3

Questions about Blackrock Pharmaceuticals

Does Blackrock Pharmaceuticals hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Blackrock Pharmaceuticals. It does have 5 filings with 2 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Where does Blackrock Pharmaceuticals manufacture?
3 registered sites are on record, in United Arab Emirates and United Kingdom (Marlow and High Wycombe among others). Every site is listed on this page with the register it came from.
Which regulators recognise Blackrock Pharmaceuticals's GMP?
Current GMP certificates are on record from MHRA (UK). GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Blackrock Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates